The importance of this mechanism lies in the fact that Nfatc2ip has previously been associated with maladaptive post-infarction remodeling, which places miR-31-5p at the center of a possible new molecular regulatory circuit, with clinical and legal applications in cases of sudden death associated with clinically unsuspected cardiac hypertrophy [156]. Here, NFATC2IP is linked to cardiac hypertrophy.